Our mission is to understand how cancer cells adapt to and exploit aneuploidy. 

We combine cutting edge functional genomics, bioinformatics and machine learning to develop diagnostic and therapeutic strategies to deliver the next generation of precision oncology based on large-scale alterations of cancer genomes. 


Key Collaborators